HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
Search for topics & keywords
Search
Shanghai Fosun Pharmaceutical (02196) spent 26.23123 million yuan to repurchase 1.1829 million A-shares on September 18th.
18/09/2024
GMT Eight
Shanghai Fosun Pharmaceutical (02196) announced that on September 18, 2024, it spent 26.23123 million yuan to repurchase 1.1829 million A shares.
HUISHANG BANK (03698): Lu Hao's qualification as a non-executive director has been approved.
Hybio Pharmaceutical(300199.SZ): Aselegine Injection approved for listing, used to improve blood sugar control in type 2 diabetes patients.
RECOMMEND
Heavy cash out, Buffett reduced 57 billion yuan in 2 months!
58 min ago
How does the Fed rate cut affect overseas markets? Sealand: Hong Kong stocks in the technology sector perform well under loose trading conditions.
2 h ago
Zhongtai: A shares focus on stability, pay attention to opportunities in public utilities such as nuclear power and telecommunications operators.
2 h ago
©️2013 - 2024 GMT EIGHT Holdings. All Rights Reserved.
Contact: contact@gmteight.com